-
Mashup Score: 13
Leukemia – Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
Source: www.nature.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 32
Leukemia – Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients | Leukemia https://t.co/apzxedGqDf
-
-
Mashup Score: 0Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report - 1 year(s) ago
Leukemia – Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report. https://t.co/KB9t2X2DBr
-
-
Mashup Score: 19
Leukemia – The evolution of preclinical models for myelodysplastic neoplasms
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
The evolution of preclinical models for myelodysplastic neoplasms. https://t.co/SRuPxVksa1
-
-
Mashup Score: 33
Blood Cancer Journal – Update on the management of relapsed/refractory chronic lymphocytic leukemia
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Update on the management of relapsed/refractory chronic lymphocytic leukemia | Blood Cancer Journal https://t.co/e2JjlIm6Ur
-
-
Mashup Score: 12
Leukemia – The evolution of preclinical models for myelodysplastic neoplasms
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
The evolution of preclinical models for myelodysplastic neoplasms. https://t.co/SRuPxVkZZz
-
-
Mashup Score: 1Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia - 1 year(s) ago
Blood Cancer Journal – Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia | Blood Cancer Journal https://t.co/Vn3u7ZEdxo
-
-
Mashup Score: 2Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study - 1 year(s) ago
Blood Cancer Journal – Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study | Blood Cancer Journal https://t.co/QcFujHKdKr
-
-
Mashup Score: 30
Blood Cancer Journal – Update on the management of relapsed/refractory chronic lymphocytic leukemia
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Update on the management of relapsed/refractory chronic lymphocytic leukemia | Blood Cancer Journal https://t.co/e2JjlIm6Ur
-
-
Mashup Score: 12
Leukemia – The evolution of preclinical models for myelodysplastic neoplasms
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
The evolution of preclinical models for myelodysplastic neoplasms. https://t.co/SRuPxVkZZz
-
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results | Leukemia https://t.co/J6uK3OCwo5